Sorafenib

cyclin dependent kinase inhibitor 2A ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30154433 ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib. 2018 Aug 28 6
2 25862847 Targeting mTOR and AREG with everolimus, sunitinib and sorafenib in HPV-positive and -negative SCC. 2015 Apr 1
3 23724131 Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection. 2013 4